switching from insulin to glp-1 Favorable Effects of Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine Schematic pathway showing release of

Inject once daily, subcutaneously, rotating between the abdomen, thighs, and upper arms

Student IV Therapy Price: R750 Infusion Time: 45 minutes Obgyn IV Therapy Price: R850 Infusion Time: 45 minutes Liquid Multivitamin IV Therapy Price: R1 050 Infusion Time: 45 minutes Weight Loss IV Therapy Price: R1 200 Infusion Time: 45 minutes Hangover IV Therapy Price: R1 250 Infusion Time: 45 minutes NAD+ IV Therapy Price: R1 300 R10 600 Infusion Time: 90 120 minutes Super Immune Boost IV Therapy Price: R1 350 Infusion Time: 45 minutes Super Skin Glow IV Therapy Price: R1 350 Infusion Time: 45 minutes Energy Boost IV Therapy Price: R1 500 Infusion Time: 45 minutes Detox IV Therapy Price: R1 550 Infusion Time: 45 minutes High Performance & Endurance IV Therapy Price: R1 700 Infusion Time: 45 minutes Anti-Aging IV Therapy Price: R1 850 Infusion Time: 45 minutes Cardiac IV Therapy Price: R1 850 Infusion Time: 60 minutes Sinus & Allergy IV Therapy Price: R1 950 Infusion Time: 60 minutes Asthma IV Therapy Price: R1 950 Infusion Time: 90 minutes Mental Clarity IV Therapy Price: R2 150 Infusion Time: 45 minutes Signature IV Therapy Price: R2 650 Infusion Time: 45 minutes Hair Grow IV Therapy Price: R2 750 Infusion Time: 90 minutes Libido IV Therapy Price: R3 050 Infusion Time: 90 minutes

Lancet 387:67990

While these findings are not established in MASH models, they provide a mechanistic basis for hypothesizing that these immunometabolic alterations are relevant to obesity-associated liver disease

Retatrutide is a triple-agonist that activates GLP1, GIP, and glucagon receptors